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Summary
We present evidence that direct T cell receptor (TCR) occupancy by antigen can either activate
or inhibit T cells, depending upon whether or not a threshold number oflocalTCRs are crosslinked
by multivalent arrays of the antigen . Variants of Jurkat cells were previously transfected with
TCR a and (3 chains that bind fluorescein, yielding FLTCR+ human T cells. The transfectants
are activated upon binding soluble multivalent antigen arrays at concentrations well below those
required for monovalent interactions . This activation, measured by calcium fluxes and interleukin
2 (IL-2) production, indicates the superior binding avidity of multivalent ligands . Smaller, less
multivalent arrays do not activate the cells, but antagonize larger arrays, demonstrating that antigen
can bind TCR as either agonist or antagonist . The balance between activation and inhibition
depends upon antigen array size, ligand valence, and concentration, indicating that a threshold
extent of receptor crosslinking, and not individual perturbations of single TCR, is required for
activation by antigen . Approximately 100 stimulatory arrays specifically bind per FLTCR+ cell
at concentrations where IL-2 production is half-maximal .
T cells are activated by antigen fragments bound toMHC
gene products on APCs (1) . Specific T cell activation
is mediated byTCR a and /3 chains, which have dual specificity
for antigens andMHC proteins (2-6) . Interactions between
TCRs and TCR ligands (either MHC-peptide complexes or
antiTCR Abs) result in a cascade of events, including phos-
phatidylinositol metabolism and calcium fluxes, protein phos-
phorylation and dephosphorylation, and coordinate immediate
early gene activation, lymphokine secretion, cytokine receptor
expression, and cellular proliferation (7, 8) .
As noted recently, "the key question is whetherT cell trig-
gering involves crosslinking of theTCR molecules, or whether
activation occurs by perturbation of a TCR multi-molecular
complex by a single MHC-peptide" (9) . It has long been
known that antiTCR Abs or peptide-MHC complexes alone
can activate T cells when immobilized in highly multivalent
form on beads, presenting cells, or planar membranes (10,
11) . However, the valence of antigen and thenumber of cross-
linked TCRs required for activation has remained unclear,
because quantitation ofTCR interactions with such solid phase
ligands has remained experimentally difficult (12-14) .
To begin to answer this question, several laboratories have
recently prepared homogeneous, soluble TCR antigens
(MHC-peptide complexes) and TCRs, which have revealed
that monovalent TCR-ligand interactions are of low affinity
(Kd - 10-5 to 10-6 M ; 15-18) . To overcome these low
affinities of monovalentTCRligand binding, both interac-
tions with accessory molecules, and multivalent TCR-MHC
peptide interactions, have been proposed to explain the ex-
quisite specificity for antigen by T cells (17-19) .
It remains unclear, howTCR ligation by nominal antigen
on APCs is related to TCR crosslinking by antiTCR Abs,
although both signals trigger qualitatively similar biochem-
ical responses (1) . In an effort to bridge this important gap,
we have used an experimental system where hapten antigen
binds TCR a and a heterodimers directly, without ligation
ofMHC or accessory proteins and without resulting syner-
gistic and/or antagonistic effects (15, 20, 21) . It is notable
that other hapten-specific T cells that bind antigen in the
absence ofMHC proteins have also been described, although
most TCRs bind peptide-MHC complexes (1, 22-25) .
We chose to study the function of soluble fluorescein an-
tigen arrays because they could be systematically varied with
respect to valence and physical size . Such a range of valences
has not yet been studied using either soluble MHC-peptide
complexes or antiTCR antibody. Additionally, the study of
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would be simplified by varying the defined, soluble antigen
arrays as the sole experimental variable. Ourstudy differsfrom
previous work in that : (a) soluble, multivalent antigen, rather
than antibodies directed against TCRepitopes, was studied ;
(b) antigen arrays were systematically varied to includeawide
range of valences that have not been studied with pep-
tide-MHC complexesor antibody Fabfragments, to analyze
requirements for TCR crosslinking by antigen ; (c) soluble,
radiolabeled arrays were used, facilitating direct quantitation
ofbinding (without fluorescence quenching) ; and (d) corre-
lationswere made between direct antigen binding andT cell
function .
Some of the soluble antigen arrays activate T cells at con-
centrations far below the Kd of monovalent TCR-antigen
interactions (15), which indicates that multivalentTCRligand
binding can indeed occur with great avidity (i.e., effective
affinity), despite such weak monovalent TCR-ligand inter-
actions. We report belowthat directTCR occupancyby mul-
tivalent antigen can inhibit or activateT cells, which strongly
suggests that athreshold number oflocalTCRs must be coor-
dinately ligated (crosslinked) for activation of calcium fluxes
and IL-2 production . Furthermore, the results suggest that
single TCR-antigen interactions do not trigger such T cell
functions.
Materials and Methods
Cells, Culture Media, and 11,2 Assay.
￿
Jurkat cells and fluores-
cein (FL)'TCR' transfected Jurkat cells (derived from TCR 0-
Jurkat 31-13 cells; [15, 21]) were grown and assayed in complete
medium, using Eagle's MEM, suspension salts (Gibco Laborato-
ries, Grand Island, NY) supplemented with nonessential amino
acids, 2 mM glutamine, 1 mM sodium pyruvate, 50 pM 2-ME,
essential amino acids, 1 g/liter dextrose, and 10% (vol/vol) FCS
(Hyclone Laboratories, Inc., Logan, UT) as described (2). To main-
tain long-term episomal expression ofTCR in stable transfectants,
geneticin and hygromycin were each added to complete medium
at 0.5 mg/ml (21) . For IL-2-assay, T cells were cultured overnight
in 0.3 ml complete medium in flat-bottomed microculture plates
(Costar, Cambridge, MA), pelleted by centrifugation at 250g for
10 min, and 0.1 ml sterile culture supernatants were removed and
incubated overnight with IL-2-dependent CTLL2 cells. Thepro-
liferation of IL-2-dependent cells was assessed by measuring
['H]thymidine incorporation after overnight incubation with
1 ACi ['H]thymidine (Amersham Corp., Arlington Heights, IL)
using a PhD cell harvester (Cambridge Technology, Inc., Cam-
bridge,MA) and glass fiber filters (Schleicher&Schuell, Inc., Keene,
NH) as described (26) .
Synthesis, Purification, and Characterization of TCR Ligand
Arrays. Fluorescein arrays were prepared as previously described
(27), by derivatizing size-fractionated polyaminoethyldextran, poly-
aminoethylficoll, or polyaminoethylpolyacrylamide with fluores-
cein isothiocyanate (isomer I ; Sigma Chemical Co., St . Louis, MO,
or Molecular Probes, Eugene, OR) or other fluorophores. Excess
fluorescein was removed by exhaustive dialysis . The mass of an-
tigen arrays was determined after dialysis against deionized water
and drying undervacuum to constant weights . Acharacteristic value
i Abbreviation used in this paper. FL, fluorescein .
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for refractive index per mass was determined for each arraychem-
istry, using a variety of reference solvents . The molecular weight
distribution ofpurified antigen arrays in aqueous solution was de-
termined after fractionation in 0.1M potassium phosphate buffer
containing 20% (vol/vol) acetonitrile, pH 8, on tandem Superose
6 and Superose 12 fast protein liquid chromatography (FPLC)
columns (Pharmacia, Piscataway,NJ ; and HP-1090 liquid chromato-
graph ; Hewlett-Packard Co., Palo Alto, CA), by measuring light
scattering and refractive index using a Dawn F laser photometer
and Wyatt Optilab 903 refractometer (Wyatt Technology Corp.,
Santa Barbara, CA) (28) . Ligand valence was determined by spectro-
photometry at 496 nm using a molar extinction coefficient of72,000
M- ' (diode array spectrophotometer model 8451A ; Hewlett
Packard) .
Intracellular Calcium Measurements.
￿
FLTCR' transfectants were
loaded with 2.5 p,M Indo-1 AM (Molecular Probes, Eugene, OR)
for at least 30 min at 37°C . Single cell intracellular calcium mea-
surements were determined at 37'C as described, by measuring
the ratio of emissions at 410 and 490 nm upon excitation at 370
nm using a flow cytometer (Coulter Electronics Inc., Hialeah, FL)
and Cicero software (Cytomation Inc., Fort Collins, CO) (29) .
As a positive control, the ratio of emissions was determined for
cells treated with antiTCR antibody (2Ad2A2, kindly provided
by Dr. R . Siliciano, Johns Hopkins) or ionomycin . No PMA was
added during any of the calcium measurements .
RadiolabeledArrays andBinding Experiments.
￿
Fluorescein arrays
were diluted in 0.1 M potassium phosphate buffer, pH 8, to 2 x
10- 'M fluorescein, 0.5 mCi Na 1211 (Dupont-New England Nu-
clear, Boston, MA) was added in 50 /AL of the same buffer, and
the mixture incubated with an Iodobead (Pierce Chemical Co.,
Rockford, IL) for30 min at 23'C on a nutating platform . Trace-
labeled arrays (with<1/100 fluoresceins iodinated) were separated
from free Na 1251 using a 10 ml desalting column (Speedy; Pierce
ChemicalCo.) preequilibrated in PBS . Specific activity of the iodi-
nated arrays was determined by measuring radioactivity and
OD496 . Cells were incubated at 4'C with various concentrations
of radiolabeled F1u96ODex2300, with or without excess identical un-
labeled competitor overnight, and then were washed at least three
times through ice-cold FCS by centrifugation at 4'C and aspira-
tion ofsupernatants using a30-gauge needle . Radioactivity of cell
pellets was determined. The number of arrays bound per cell was
calculated, using the specific activity of the arrays and assuming
quantitative recovery of cells .
Results
FLTCR' T Cells Are Specifically Activated by Soluble An-
tigen Arrays, Resulting in Bell-shapedDose Response Curves. T
cell clones that proliferate in response to soluble fluorescein
arrays have been isolated, and theirTCR ci and0 chains pre-
viously were transfected into a TCR a
_ variant of Jurkat
cells, yielding FLTCR' T cells (21) . Jurkat cells are a widely
used human tumor cell line that mimics resting peripheral
humanTcells. These cells secrete IL-2upon incubation with
a combination of soluble antiTCR antibody and PMA, as
part of the multifaceted processes ofT cell activation (7) .
To confirm that the transfected cells specifically and directly
are activated by fluorescein antigen, Jurkat cells or FLTCR'
transfectants were incubated with PMA at 3 ng/ml and var-
ious concentrations of a physically defined, soluble fluores-
cein array with "3,600 fluoresceins per 107 Da mass dex-
tran polymer backbone. We assayed T cell activation byN V !--~ C
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Figure 1 .
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Soluble antigen polymers specifically activate FUTCR+ trans-
fectants . Comparison of IL-2 production by Jurkat cells (F~) vs . FLTCR+
transfectants (/) incubated with soluble fluorescein array. Cells were cul-
tured at 2 x 105/ml with indicated concentrations of FL3,6ooDex10,000 kn
and with PMA added at 3 ng/ml . Culture supernatants were harvested
and assayed for IL-2 concentration using IL-2-dependent CTLL2 cells . As
control, maximum [3H]thymidine incorporation by CTLL2 cells with ex-
ogenous IL-2 was 380,000 cpm ; without added 11,2, CTLL2 cells incor-
porated 1,500 cpm. Similar results were obtained in six separate experiments.
measuring IL-2 production . T cell culture supernatants were
harvested and thymidine incorporation was determined using
IL-2-dependent cells (CTLL2 [26]) . As shown in Fig. 1, un-
transfected Jurkat cells did not produce IL-2 when treated
with PMA and these soluble fluorescein-dextran arrays at any
concentration . However, FLTCR+ transfectants, which bear
T cell antigen receptors that specifically bind fluorescein in
the absence ofMHC gene products (21), produced IL-2when
so treated . Moreover, FLTCR+ transfectants were not
stimulated under similar conditions by arrays bearing Texas
red or rhodamine, two structural analogs of fluorescein (D .
Symer, unpublished data) . The results verify that FLTCR+
cells, unlike the parental Jurkat cells which express different
TCR ci and (3 chains, are activated by fluorescein arrays
specifically (21) .
FLTCR+ Jurkat transfectants produced IL-2 in response
to antiTCR antibody and PMA under conditions similar to
those previously described as activating the parental Jurkat
cells (7) . The total secreted IL-2 was about 50% less by FL
TCR+ cells than by parentalJurkat cells, at similar doses of
antiTCR antibody, consistent with lower levels of total TCR
expression by the former cells (21) .
A biphasic pattern of increasing and then decreasingT cell
activation, measured by IL-2 production, is observed with
increasing antigen array and constant PMA concentrations
(Fig . 1) . Such a "bell-shaped" dose-response relationship has
previously been observed with increasing TCR antigen or
with increasingMHC gene product concentrations (30), al-
though the reasons for these effects with soluble vs . surface-
bound TCR ligands may be different . A possible mechanism
accounting for our findings (Fig. 1) is that, at high doses,
the antigen arrays would be toxic to cells. In three separate
experiments, we have observed no significant difference in
proliferation of cells treated with fluorescein arrays even at
10 -4 M fluorescein moiety concentrations, ruling out cell
death (apoptosis) as a cause of decreased IL-2 production at
high antigen concentrations .
Another possible mechanism that would account for these
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bell-shaped dose-response curves is that thresholds of TCR
multimerization must be exceeded for T cell activation . At
high concentrations ofTCR ligands such as the soluble an-
tigen arrays, individual arrays would not crosslink a threshold
number of neighboringTCRs to activate the T cell, because
of competition between the numerous such arrays binding
neighboring TCRs. According to this model, smaller and
less multivalent arrays would not activateT cells, because they
would not crosslink enough neighboring TCRs at any con-
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￿
Physical properties ofantigenpolymers. (a) Chemical linkages
of fluorescein isothiocyanate, isomer 1, to polaycrylamide (left) and to dex-
tran or Ficoll (right) . (b) Fractionation of a representative fluorescein-Ficoll
array sample in aqueous solution, by HPLC gel filtration . Voltage signals
indicating 90° laser light scattering (heavy line) and refractive index (thin
line) are shown as a function of its elution volume . (c) Molecular weight
distribution of the array sample as a function of its elution volume, calcu-
lated from laser light scattering and refractive index (28) .centration . To test whether individual perturbations of single
TCR by antigen would or would not trigger cell activation,
we synthesized and characterized a series of related antigen
arrays.
Physical Characteristics ofSoluble Antigen Arrays.
￿
Related,
soluble antigen arrays were synthesized, using various car-
rier molecules of different size and chemistry, and bearing
different numbers of fluorescein ligands. The chemical linkages
offluorescein-polyacrylamide and fluorescein-dextran arrays,
used below, are depicted in Fig . 2 a . These ligand arrays were
purified to relative homogeneity as described (20, 27) . Similar
ligand arrays activate and/or inhibit both T-independent and
high affinity, Tdependent IgG and IgE immune responses
in vivo (31 ; Symer, D ., J. Reim, S . Schneider, R . Z. Dintzis,
and H . M . Dintzis, unpublished data) .
Using a new method, we characterized physical sizes and
ligand valences of the arrays in solution by measuring laser
light scattering, refractive index, and optical density. The mea-
sured 90° light scattering and refractive index of a typical
antigen array sample, fractionated by HPLC gel filtration,
are shown in Fig . 2 b . Based on such measurements, the cal-
culated molecular weight distribution for the eluted sample
in solution isshown in Fig . 2 c . Clearly, the molecular weights
of individual array molecules comprising this sample are not
identical, and range from 45 to 60 kD . The mean molecular
mass for the arrays of the sample is 53 kD, and >95% of
the array molecules are within 15% of the mean . Antigen
valence was determined by measuring optical density for
samples ofknown mass and average molecular weight as de-
scribed (27) . We found that about 12 fluoresceins are on the
53-kD Ficoll backbones, and so this relatively homogeneous
sample is designated as F1u12Fic53 . A summary of the average
molecular weights and valences of antigen arrays used in this
paper, determined as shown in Fig . 2, b and c, and/or by
sedimentation equilibrium as described (27), is presented in
Table 1 .
Table 1.
￿
Defined, Soluble Antigen Arrays
Summary of average sizes and ligand valences of antigen arrays . Average
values were calculated using data as shown in Fig . 2 . Ligand valence was
determined by measuring OD at 496 nm . Concentrations of arrays were
determined by measuring dry weights of representative samples as de-
scribed (27) .
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Activation ofFLTCR + T Cells Is Determined by Array Size
and Ligand Valence. To test the proposed model as an expla-
nation for observed bell-shaped dose-response curves in T
cell activation, we tested the relative efficacy of antigen arrays
that were varied with respect to ligand multiplicity and car-
rier mass (at approximately constant ligand density) . As shown
in Fig. 3, two different multivalent array samples, FL5oFic2oo
and FL26oFic77o, stimulated IL-2 production in a bell-shaped
pattern as a function of dose. By contrast, physically smaller
arrays of lower ligand multiplicity, i.e., oligovalent FL2oFic96
and FL12Fic53, did not induce substantial IL-2 production at
any concentration . Total input fluorescein and backbone mass
concentrations were equivalent for both stimulatory and non-
stimulatory arrays (i .e ., they were all of approximately con-
stant ligand density) . Additionally, bell-shaped dose-response
patterns were obtained when large, densely haptenated
fluorescein-polyacrylamide or fluorescein-dextran arrays were
tested . We have not yet determined what array sizes and va-
lences define the transition between stimulatory and non-
stimulatory properties of polyacrylamide carriers.
Smaller, oligovalent arrays such as FL2oFic96 and FL12Fic53
did not induce substantial IL-2 production at any concentra-
tion . The results (Figs . 1 and 3) are consistent with the above
model thatmay account for bell-shaped dose-response curves :
the fluorescein multiplicity and/or array size of FL2oFic96 and
FL12Fic53 may not be sufficiently large, resulting in in-
sufficient coordinate ligation of TCR by individual antigen
arrays .
Antigen-speck Inhibition ofT CellActivation Using Oligovalent
Arrays. It is possible that nonstimulatory arrays, with ligand
valence < about 20, did not activate the FLTCR+ cells be-
cause they did not bind the cells at all . To test this possi-
bility, we determined whether smaller, oligovalent arrays could
inhibit activation by stimulatory arrays . As shown in Fig.
4 a, oligovalent FL8Dex21 at any concentration failed to
stimulate IL-2 production, confirming the results shown in
Fig. 3 with fluorescein-Ficoll, a different chemical backbone.
As positive control, FL5oFic2oo was tested separately at var-
Antigen Arrays Control T Cell Responses
Figure 3 .
￿
IL-2 production by FLTCR+ transfectants is controlled by
array size and valence. Comparison ofIL-2 stimulation using antigen arrays
of different size and valence. FLTCR' transfected cells at 3 x 105/ml
were incubated with various concentrations offluorescein-Ficools of similar
ligand density per mass carrier backbone : (A) F15oFic2oo; (") F126oFic77o ;
(A) F12oFic96 ; and (0) F112Fics3 . Culture supernatants were harvested and
assayed for IL-2 content, by measuring [ 3H]thymidine incorporation by
IL-2-dependent cells. Similar results were obtained in at least two separate
experiments .
Name Backbone
Fluorescein
valence
Average array
size
Da
Flu 12Fic53 Ficoll 12 per array 53,000
Flu2oFic 96 Ficoll 20 96,000
Flu5OFic2 oo Ficoll 50 200,000
FlumoFic 77o Ficoll 260 770,000
Flu8Dex2 1 Dextran 8 21,000
F1u96oDex2300 Dextran 960 2,300,000
FIUMwDexloooo Dextran 3,600 10,000,000
Flu15oPA63o Polyacrylamide 150 630,000. N .7 u
200001
[fluorescein polymer], jig / mL
Figure 4 .
￿
Inhibition of T cell activation using nonstimulatory antigen
arrays. (a) FLTcR' transfectants were cultured overnight at 7 x 105
cells/ml with PMA at 3 ng/ml and various concentrations of FL5OFic2OO
(0) or FL8Dex21 (/) . Culture supernatants were harvested and assayed
for IL-2 by measuring proliferation of IL-2-dependent cells . (b) Inhibition
of IL-2 production, stimulated as in (a) by FL50Fic2OO, using nonstimula-
tory FL8Dex21 : (0) no added FL8Dex21 ; (A) 0 .5 wg FL8Dex21/ml; (X)
5 t~g FL8Dex21/ml ; (/) 15 Etg FL8Dex21/ml . Conditions for IL-2 assay
were as in (a) .
ious doses . We determined whether antigen-specific inhibi-
tion of T cell activation occurs when oligovalent antigen is
added. As shown in Fig. 4 b, various doses of FL8Dex21 were
added in combination with stimulatory FL5oFic2oo . The in-
duction of IL-2 by the latter antigen array was inhibited by
excess doses of the nonstimulatory array.
Antigen arrays, both oligovalent and multivalent, at epi-
tope concentrations >10 -4 M fluorescein, are not toxic to
FLTCR+ cells or in the IL-2 bioassay, because transfected
cells and IL-2-dependent cells each proliferate normally in
their presence as measured by vital dye exclusion and thymi-
dine incorporation (data not shown) .
It is notable that the oligovalent array FL8DeX21 added in
Fig . 4 is different from the stimulatory FL5oFic2oo array, in
its carrier backbone. Results similar to those in Fig . 4 were
obtained when both stimulatory and inhibitory arrays are com-
prised of the same carrier . Moreover, no inhibition of activa-
tion by stimulatory arrays was observed when a vast excess
of nonfluoresceinated backbone molecules (i .e., no specific
ligands) was added(D. Symer, unpublished data) . The results
demonstrate that inhibition does not occur by nonspecific
competition between carriers per se, because arrays of appropri-
ately low ligand multiplicity can effectively inhibit stimula-
tory arrays comprised of different carrier chemistry. The results
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also demonstrate that the oligovalent arrays specifically bind
to FLTCR . Binding sufficient to inhibit activation by more
multivalent arrays occurs, even though the more multivalent
arrays may bind with greater effective affinity (20) .
Inhibition or Activation ofIntracellular Calcium Fluxes by TCR
LigandArrays . As described above, a clear distinction could
be made between antigen arrays that induce IL -2 production
and those that do not . Arrays having greater than about 100
kD mass and 50 TCR ligands were stimulatory (i.e., mul-
tivalent), whereas those with less than about 20 fluoresceins
were not (i.e., oligovalent) . We tested whether the antigen
arrays similarly could be divided according to their efficacy
in activating more immediate signals in T cells . Intracellular
calcium concentrations rise after only several seconds upon
adding crosslinking antiTCR antibody (7, 32) . These rises
in intracellular calcium are thought to occur after activation
of tyrosine kinases (33, 34) .
FLTCR+ transfectants were loaded with a calcium-
sensitive, fluorescent dye, i .e ., Indo-1 AM . Intracellular cal-
cium concentrations were determined for individual cells as
a function of time by measuring the ratio of fluorescence emis-
sions at two wavelengths, using flow cytometry as described
(29) . The ratio of violet to blue fluorescence emissions in-
creases as Indo-1 binds increasing intracellular free calcium .
As shown in Fig . 5, a, b, and e, the larger antigen poly-
mers FL50FiC200 and FL15oPA63o induced rapid, substantial,
dose-dependent rises in intracellular calcium in FLTCR+
transfected T cells in the absence ofPMA. By contrast, different
doses of smaller, more oligovalent FL12Fic53, which did not
induce IL-2 production (Fig. 3), also failed to induce sub-
stantial calcium fluxes compared with untreated cells as shown
in Fig. 5, c and d . Furthermore, when FL 12Fic5 3 was added
at doses where stimulatory arrays were effective, i.e., at iden-
0
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Figure 5 .
￿
Activation and inhibition of intracellular calcium fluxes by
stimulatory vs . nonstimulatory antigen arrays . FLTCR' transfected cells
at 106 cells/ml culture medium were incubated at 37°C with 25 'UM
Indo-1 AM. After at least 30 min of incubation, intracellular calcium levels
were determined for individual cells at 37°C, as a function of time. At
time t = 20 s, TCR ligands were added at indicated final concentrations :
(a) FL5oFic2oo at 2.5 /1g/ml ; (b) FLsoPic2oo at 25 hg/ml; (c) F112Fic53 at
400 kg/ml followed at t = 225 s by F15oFic2w at 2.5 wg ml; (d) FL12Fic53
at 400 gg/ml followed at t = 300 s by FL5oFic2oo at 25 ug/ml ; (e) FL1so-
PA63o at 25 ug/ml . Data are plotted as isograms, with outermost con-
tours representing 16 cells/s, then 32, 64, and 128, and were gated for
single cells whose emission ratio was greater than or equal to the median
ratio, arbitrarily set to 1 (29) . This ratio corresponds to [Cali ^+ 100 nM,
whereas a maximal ratio of 4 is ti 1,000 nM free calcium . NoPMA was
added in this experiment . Similar results were obtained in three separate
experiments .tical concentrations of fluorescein, it again did not cause a
rise in calcium concentrations (D. Symer, unpublished data).
After adding nonstimulatory FL12Fic53 and waiting for <5
min, we added stimulatory FL5oFic2oo at the times indicated
by arrows in Fig. 5, c and d. In both cases, the calcium flux
induced by stimulatory polymer (as in Fig. 5, a and b) was
dramatically reduced in most cells (compare a and d, or b
and c). It is notable that the response to anti TCR mAb
2Ad2A2 (7) proceeded normally in the presence of oligova-
lent arrays such as FL12Fic53 (D. Symer, unpublished data).
This result demonstrates that inhibition ofcalcium fluxes by
oligovalent arrays does not occur by toxicity or by down-
stream uncoupling ofTCRmediated signal transduction. Fur-
thermore, the time necessary for inhibition is brief, as at most
only a few minutes are required for induction of observed
suppressive effects.
The resting concentration of free intracellular calcium in
Jurkat cells has been reported to be about 100 nM, which
would correspond to a normalized ratio of 1 as shown in
Fig. 5 (29). Based on this value, we estimate that maximal
intracellular calcium, corresponding to a ratio of about 4,
is about 1,000 nM free calcium in the activated FLTCR+
cells.
Estimation ofthe Number ofAntigen Arrays Needed to Acti-
vate FLTCR + Transfectants. Previous reports have indicated
that about 200 TCR ligands (either peptide-MHC complexes
or anti TCR mAbs) on a single APC or bead were necessary
to activate IL-2 production by T cells at a minimally detect-
able level (12, 13), although larger numbers were obtained
in a different experimental system (35). To correlate direct
binding with T cell function, we sought to determine how
many antigen arrays are directly bound to FLTCR+ cells at
concentrations where IL-2 production is half-maximal, be-
cause it is difficult to extrapolate to very low concentrations
ofbound ligands given the inherent heterogeneity ofreceptor
numbers per cell and of cell responses (21, 36).
When fluorescein is bound by different specific mAbs, its
fluorescence is variably quenched (37, and Schneider, S., and
H. M. Dintzis, unpublished data). Therefore, for unambig-
uous quantitation ofbinding, we trace-labeled antigen arrays,
with less than one per hundred fluoresceins radioiodinated,
to measure binding to FLTCR+ cells. As shown in Fig. 6
a, binding of a large, multivalent, radiolabeled ligand array,
which increases with increasing concentration, was substan-
tially reduced by excess identical unlabeled competitor, indi-
cating that binding is specific. As another control for specificity,
we added excess unlabeled multivalent fluorescein-polyacryl-
amide arrays in a different experiment, and again observed
substantial competition using the different chemical back-
bone (data not shown).
Using the specific activity ofradiolabeled ligand arrays and
the concentrations of FLTCR+ cells, we calculated the
number of specifically bound antigen arrays at various input
concentrations from data in Fig. 6 a, as shown in Fig. 6 b.
For comparison, we superimposed results from two indepen-
dent experiments measuring IL-2 production induced by the
same stimulatory arrays at 37°C. In Fig. 6 c, we ascertained
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Figure 6.
￿
Relationship between antigen array binding and IL-2 stimu-
lation. (a) Radioiodinated FL96ODex23oo was added at indicated concen-
trations to FLTCR+ cells at 1.8 x 106 cells/ml culture medium con-
taining unlabeled excess FL960DeX23oo at 10-5 M fluorescein (/); or no
competitor (A). Cells were incubated at 4° overnight with intermittent
shaking, before washing three times in ice-cold calf serum and saline. Ra-
dioactivity in cell pellets was determined as shown. Similar results were
obtained in three separate experiments. (b) Using the specific activity of
the trace-labeled antigen arrays, we calculated the number specificallybound
bycomparing amounts bound in the absenceand presence of excess inhib-
itor (closedsymbols). In two independent experiments, FLTCR+ cells were
cultured at 3 x 105 cells/ml with 3 ng/ml PMA and indicated doses of
FL96oDex23uo (open symbols). Culture supernatants were harvested after
overnight culture, and IL-2 production was assayed by determining prolifer-
ation ofIL-2-dependent cells. For comparison, the IL-2 production in the
one experiment (EI) were normalized to values of the other at -32,000
cpm; the actual maximum (11,2) of the former experiment was -80,000
cpm. (c) Linearity of1L2 bioassay over required concentration range. Var-
ious dilutions ofexogenous IL-2 were added to IL-2-dependent cells, whose
proliferation was assessed by 13H]thymidine incorporation after overnight
culture.the linearity of the IL -2 bioassay over the concentration range
tested in Fig . 6 b . Such linearity indicates that the plateau
and decrease in IL-2 concentrations induced at high TCR ligand
concentrations, as shown in Figs . 1, 3, 4, and 6 b, is not due
to saturation of the bioassay, which is linear over the relevant
range.
The number of arrays specifically bound per cell at con-
centrations where IL-2 production is half-maximal is on the
order of 100, as shown in Fig . 6 b . This number averages
the heterogeneity in binding by FLTCR transfectants (mea-
sured by FACS® analysis (Becton Dickinson & Co., Moun-
tain View, CA) ; 21) . Additionally, only a fraction of the cells
may produce IL-2, even after repeated cloning and corrections
for position in the cell cycle (36) . We do not anticipate in
this case that all 960 fluoresceins per array are simultaneously
ligated; it is not yet possible to determine how many fluores-
cein ligands on arrays are actually bound to individual TCRS.
For this reason, it is not yet possible to state exactly how
manyTCRS must be crosslinked by an array for minimal cell
activation to occur. We can only measure how many ligands
are required on the array to trigger activation .
Specific binding of arrays continues to increase at doses
where IL-2 induction begins to fall, presumably because fewer
and fewer ligands per array are occupying TCRS even as total
array binding increases . This result further substantiates the
notion that T cell activation does not always increase mono-
tonically, and may be inhibited, with increasingTCR ligand
concentrations and total TCR occupancy (30, 38) .
Discussion
In this report, we have shown that T cell inhibition or
activation can be controlled directly by antigen valence and
array size, using soluble, physically defined antigen arrays and
T cells transfected with TCR ot and R chains previously shown
to bind fluorescein . Large, multivalent antigen arrays trigger
IL-2 production by FLTCR+ Jurkat cells in the presence of
phorbol esters, but without accessory orMHC proteins, and
they trigger calcium fluxes even in the absence of phorbol
esters . In contrast, TCR occupancy by smaller, less multiva-
lent antigen arrays is not sufficient for TCR-mediated sig-
naling (as measured by calcium flux and IL-2 production),
even though these arrays can inhibit activation by larger ones.
Activation is specific, as IL-2 is not produced by untransfected
cells in response to fluorescein polymers (Fig. 3) or by trans-
fected cells in response to arrays ofantigen analogs (21) . Both
activation and inhibition of transfected T cells occur with
different carrier chemistries, indicating that the observed effects
do not result from special properties of a particular class of
carrier molecules. A model depicting the results is shown
in Fig . 7 .
Single cell calcium measurements (Fig. 5) demonstrate that
occupancy ofTCRS by smaller, oligovalent antigen arrays is
not sufficient for induction of calcium fluxes. Rather, TCRS
must be coordinately ligated by adequately large and multi-
meric antigen arrays to activate cells . Smaller, oligovalent arrays
could therefore be used to antagonize T cell activation, pre-
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A model ofT cell activation andinhibition by defined, soluble
antigen arrays.
sumably by competitively and nonproductively bindingTCR .
The results also verify that cell-cell contacts are not required
for activation or inhibition by these soluble antigen arrays,
as measurements were obtained by flow cytometry using di-
lute cell suspensions.
Both the inhibition or activationby arrays ofdifferent va-
lence, and bell-shaped dose-response curves described here
(Fig . 1, 3, 4, and 6) and elsewhere (30, 38), are consistent
with a threshold number of locally occupied TCRS required
for calcium fluxes or IL-2 induction to occur. According to
this model, bell-shaped dose-response curves would result
from multivalent, soluble ligands at high concentrations
competing for neighboring receptors, minimizing receptor
multimerization by individual arrays, and thereby reducing
activation despite high overall receptor occupancy. TCR cross-
linking by multivalent antigens at intermediate concentra-
tions may result in enormously increased affinities of cyto-
plasmic ligands for intracellular sites on the multimerized
transmembrane proteins, ultimately resulting in cell activa-
tion (39, 40) . The precise molecular details ofhow tyrosine
kinases, calcium fluxes, etc., are triggered by receptor mul-timerization have not yet been elucidated . It is interesting
that other cell types exhibiting similar bell-shaped dose-re-
sponse curves may share similar receptor-associated signaling
molecules (41, 42) .
Oligovalent antigen arrays failed to stimulate, and in fact
inhibited, T cell activation as seen in Figs . 3, 4, and 5 . We
infer that these smaller antigen arrays competitively and non-
productively bind TCRs . De Magistris et al . (43) recently
reported that peptide-specific T cells could be inhibited by
peptide analogs that bind equivalently to presentingMHC
molecules . This was explained as competitive inhibition by
the analogs in binding TCRs, but it is not yet clear why
peptide-MHCTCR complexes activate whereas peptide
analog-MHCTCR complexes do not . It is possible that pep-
tide analogs could bind TCRs with lower affinities than
nominal peptides, leading to insufficient TcR multimeriza-
tion, but the precise relationship between ligation by an-
tigen-MHC complexes on APCs, TCR multimerization, and
T cell activation or inhibition remains unknown (44) . It would
be interesting to study systematically varied, soluble arrays
of homogeneous peptide-MHC complexes, to correlate di-
rect binding by these more "physiologic" TCR ligands with
cell functions .
Using soluble peptide-MHC complexes to compete with
antiidiotypic antibody in binding TCR, Matsui et al . (17)
demonstrated that the Kd for TCR-MHC-peptide complex
interactions is weak, ti4-6 x 10 -5M . The binding of solu-
bilized TCR to MHC-peptide complexes on APCs is also
weak, with Kd- 5 x 10 -6M (18) . These values are similar
to those calculated for interactions betweenFLTCRs expressed
by human T cell clones or bacterially expressed, single-
chain TCRs and fluorescein, i .e ., -5 x 10-6M and N5 x
10-5 M, respectively (15, 16) . In addition, a solubilized al-
logeneicMHC molecule antagonizes alloreactivity (presum-
ably by competition with TCR) in vitro at 10- ' M, al-
though this result is more difficult to interpret given the
heterogeneity ofMHC-antigen complexes (45) . All of the
affinities determined to date indicate that monovalent TCR-
antigen binding is weak. However, multivalent or even oligova-
lent ligand-receptor interactions are energetically favored over
monovalent interactions. Thus the effective affinity of arrays
even of only a few TCR ligands could bemuch stronger than
the weak affinities of monovalent TCR ligands (46) . Peak
cellular activation occurs at about 10 -8-10 -7M fluorescein
when stimulatory arrays are used (Figs . 1, 3, 4, and 6), about
three or four orders of magnitude less than the Kd values for
monovalent fluoresceinTCR interactions noted above. We
infer that the threshold number of ligands per array required
for T cell activation may vary between antigens, and may
be less for TCR ligands with greater affinities for TCRs, or
for arrays with greater physical flexibility, ligand density, or
steric accessibility. It is notable that the required number of
ligands may be greater than the number ofTCRs that must
actually be crosslinked to trigger activation, if some of the
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ligands remain unbound . Thus our data demonstrate that at
least two, and up to 50, local TCRs must be crosslinked by
antigen to trigger activation, even though arrays with 20
fluoresceins per array did not activate the T cells .
A threshold in transcriptional activation may result from
variable levels of transcription factor NF-AT induced in acti-
vated Jurkat cells (36) . It is possible that the thresholdnumber
of fluoresceins per array (>50), or the threshold number of
arrays per cell, both required for IL-2 production by FL
TCR+ T cells, may be linked to a threshold concentration
ofNF-AT or other factors required for transcriptional activa-
tion . We are currently attempting to determine whether in-
hibitory TCR antigen arrays induce negative regulatory signals
that prevent calcium fluxes and lymphokine production, or
whether such arrays (which occupyTCRs) induce insufficient
or no intracellular signals . A candidate negative regulatory
signal may be a nuclear transcription factor such as Nil-2-a,
which negatively regulates IL-2 gene transcription in Jurkat
cells (47) .
Similarities in amino acid sequences of Ig andTCR frame-
work domains, and in their V region gene structures, sug-
gest that ligand-receptor interactions may be physically similar
for both receptors (48) . Several crystallographic structures of
antibody-antigen complexes indicate small but significant,
or even major, conformational changes in antibody Fab do-
mains upon binding (49, 50), but such studies have not indi-
cated conformational changes in hinge or Fc domains (51) .
Other workers have inferred that intermolecular interactions
between coordinately ligated antigen receptors or associated
signaling molecules could transduce signals acrossB cellmem-
branes (42, 52-54) . Thus, the structural studies to date sug-
gest that some mechanism other than intramolecular con-
formational changes in Ig could account for transmembrane
signaling by occupied surface receptors of B cells. By analogy
(given similarities in primary sequences of Ig and TCR), there
may be a requirement for multimeric receptor ligation in T
cell activation, as postulated for B cells. Imminent crystallo-
graphic studies may help clarify this issue.
A unifying theme is emerging on the signaling properties
of several transmembrane receptor molecules or complexes,
including TCR, Ig, FceR, FcyR, epidermal growth factor
receptor, platelet-derived growth factor, and insulin receptor.
All have tyrosine kinase activities physically associated, and
all require a threshold extent of receptor multimerization for
intracellular signaling (55) . These receptors may be distin-
guished from transmembrane receptors such as (3-adrenergic
receptors which putatively undergo intramolecular, transmem-
brane conformational changes upon binding monovalent
ligands (52, 53) . We infer that oligovalent ligands for the
first class of receptors (i.e., antigens for TCR, Ig, FcR, etc.)
can bind such receptors without cellular activation, and can
inhibit activation by larger, multivalent ligand arrays. We are
currently exploring pharmacologic uses of such oligovalent
ligands as specific, competitive inhibitors .We gratefully acknowledge helpful comments regarding the work by Drs. H. S . Shin, R. F . Siliciano,
andJ . Reim .
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